cover
Brigitte E.S. Jansen

Essays on Biomedical Law and Ethics

Selected papers 2004 - 2008





BookRix GmbH & Co. KG
80331 Munich

Preface first edition

Scientific research on biomedical technologies has become one of the most important protagonists of developments and changes in the world societies. We can consider that there is a formidable impact and progress on the discussion and pressure on the political system. This pressure comes from the media because of the more and more growing development of information and providing of knowledge. So the lay man was and is confronted by increasing knowledge and moral positions ranging from cautious approval, to wait-and-see attitudes, to unconditional condemnation.

As a result of this progress law making and the influence of ethicists is increasing, esp. in countries without existing laws in this field.

The following papers are given and the colleagues and students have asked me to publish it in one volume. Therefore, I decide to take five lectures as a trial.

St. Jean Saverne , October 2008

Brigitte E.S. Jansen

Preface E-Book

 The papers were published a long time ago and they had stimulate a broad discussion.1  So I believe it can be interessting to publish a second edition, even from an historical point of view and an ebook.

 

Baden-Baden, Oktober 2017

 

 

 

 

Biotechnology and Economy: An ethical conflict of in¬terest?[1]

When confronting the issues related to developments in Biotechnology, we must repeatedly ask ourselves anew as to what can and cannot be justified in an ethical sense. For radically new ethical questions seem to arise through innovative techniques such as stem cell research or GMOS and on the other hand the so called "economic area". In the following I would like to focus more on society as on economy, because the term "economic area" is from my point of view only a synonym for the perception of society. The lay man on the street has problems to understand what happened. He is confronting with new technologies and knowledge which is mostly produced by industri­al financed. From this point of view I take as an example the German stemcell research.